Clinical Data
Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
A Focus on Clinical Research
PD
Effects of Glucose-Free Dialysis Solutions on Human Peritoneal Mesothelial Cells - Chang JM, et al.
View resource
PD
Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis - Kutner NG, et al.
View resource
PD
Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription - Davies SJ, et al.
View resource
PD
Superiority of Icodextrin Compared with 4.25% Dextrose for Peritoneal Ultrafiltration - Finkelstein F, et al.
View resource
PD
Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study. - le Poole CY, et al.
View resource
PD
A 3-Year, Prospective, Randomized, Controlled Study on Amino Acid Dialysate in Patients on CAPD - Li FK, et al.
View resource
PD
Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution - Otte K, et al.
View resource
PD
Effect of icodextrin-based dialysis solution on peritoneal leptin clearance - Opatrna S, et al.
View resource
PD
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS) - Marshall J, et al.
View resource
PD
Icodextrin Improves the Fluid Status of Peritoneal Dialysis Patients: Results of a Double-Blind Randomized Controlled Trial - Davies SJ, et al.
View resource
PD
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis - Plum J, et al.
View resource
PD